We announced the launch of a new service related to computational enzyme design at BioJapan.
On Wednesday, October 9, 2024, at the BioJapan exhibitor presentation, our COO, Ken Izumi, announced the upcoming launch of a single mutation function prediction service for precision fermentation and in vitro diagnostic enzymes on the ANCAT platform.
▼ What is ANCAT?
ANCAT is a platform provided by Amplat Inc. that allows users to perform various data analysis methods without requiring specialized knowledge.
▼ Service Overview After registering to use ANCAT
This service will provide analysis results within 48 hours by uploading sequences to the cloud.
We are preparing for a launch in early 2025. If you have any questions at this time, please feel free to reach out via the contact form.
Contact form:https://www.digzyme.com/contact/